Predictive Diagnostics Market
Predictive Diagnostics Market By Test (PCR based, NGS (sequencing) based), By Indication (Cancer, Metabolic Disorders, Neurological Disorders, Musculoskeletal Diseases), By End User, By Region - Global Market Insights 2021 to 2031
Analysis of Predictive Diagnostics Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Predictive Diagnostics Market Outlook
The healthcare industry is constantly under the pressure of improving patient care while keeping the costs under a certain limit. Predictive diagnostics is one way for healthcare organizations to achieve success at enhanced outcomes at much lower costs.
With advancements in data-based technologies and their convergence with healthcare practices, the adoption of predictive diagnostics is expected to transform the way the healthcare industry works.
Manufacturers are incorporating advanced technologies such as Artificial Intelligence (AI), business intelligence (BI), Machine Learning (ML), and advanced data analytics to reach the highest levels of accuracy in their products.
The future of the healthcare industry is expected to be redefined by the growing adoption of predictive diagnostics, and this signals the positive growth of the predictive diagnostics market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Insights by Test Type
Polymerase chain reaction (PCR) is one of the most popular and commonly-used categories of molecular diagnostic tests implemented as a part of various healthcare treatments.
Mainly due to the fact that PCR-based tests are highly sensitive tests with lower parasite load, they are especially relevant in chronic cutaneous lesions.
This is one of the prominent growth prospects for manufacturers of PCR-based predictive diagnostic tools. As PCR-based predictive diagnostic tests are considered among the most accurate diagnostic methods, their adoption is expected to remain significantly high in the coming years.
While the popularity of PCR-based predictive diagnostics continues to grow, the adoption of next-generation sequencing (NGS) platforms is also picking pace in the predictive diagnostics market.
The advancements in the data sequencing methodologies is expected to trigger automation in diagnostic testing, and this is also expected to boost the adoption of NSG-based predictive diagnostics among end users, setting a new trend in the market in the coming future.
Predictive Diagnostics in Cancer Detection
Key players in the predictive diagnostics market are expected to witness high revenue flows from the predictive diagnostic tools and predictive testing equipment used for the prediction of the risk of cancer.
Though cancer is not a genetic disorder, some types of cancer such as breast, ovarian cancer, and colorectal cancer can be transferred genetically.
Growing prevalence of these types of cancer is triggering patients, mainly women, to opt for predictive testing to identify their exposure to the risk of getting affected by these diseases.
Manufacturers in the predictive diagnostics market are upscaling the production as well as research & development of innovative, high-tech tools for accurately predicting the risk of cancer.
Market players are also expanding their networks beyond investors to include subject matter experts and researchers to gain a competitive edge in the segment.
In the coming years, along with cancer, manufacturers are expected to increase focus on introducing predictive diagnostic tools for neurological and metabolic disorders to diversify their product offerings.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Predictive Diagnostics Market by End User
The adoption of predictive diagnostics is significantly high in various healthcare organizations including diagnostic centers, genetic laboratories and clinics, and research and academic institutes.
Growing awareness about predictive diagnostics across these end user segments is expected to drive the growth of the market.
The demand for predictive diagnostic tools is expected to remain significantly high in diagnostic centers, as the end users segment is rapidly moving towards adopting the trend of predictive medicine and precision treatment.
A mounting number of diagnostic labs are expected to set an aim of using sophisticated technologies in diagnostics to boost the use of precision medicine treatment and testing in order to dramatically enhance patient care.
Healthcare service providers are seeking diagnostic tools to predict how patients will react to medications and based on which, a proper treatment can be planned for improving patient outcomes.
Genetic laboratories are also expected to utilize predictive diagnostics to add innovative clinical services by creating digital decision support through such high-tech tools for improved clinical care at controlled costs.
Regional Outlook on Predictive Diagnostics Market
The adoption of predictive diagnostic equipment is significantly high in US and Europe, mainly attributing to the increasing integration of technologies in the healthcare industry.
Significant presence of global players in the region also makes North America a leaving market for predictive diagnostics. Market leaders are also collaborating to discover novel disease triggers through the use of next-generation technologies and develop therapies for effective treatment.
This is expected to further bolster the growth of the North America predictive diagnostics market.
Along with North America, Asia Pacific is also emerging as a profitable region for players in the global predictive diagnostics market.
A significant surge in healthcare spending and growing customer awareness about health and wellbeing is expected to create new opportunities for predictive diagnostic tools in the region.
Prominent players in the market are tapping into the regional opportunities by expanding their presence in developing economies through their distribution partners.
Key Players
Key players in the global predictive diagnostics market are Abbott Laboratories, Therawis, F.Hoffmann-La Roche Ltd., BIOMÉRIEUX SA, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad, Myriad Genetics, Inc., Genesis Genetics, Centogene N.V., BGI, 23andMe, Inc., Predictive Oncology, Counsyl, Inc., Bio-Rad Laboratories Inc., Mylab Discovery Solutions Pvt. Ltd., and ARUP Laboratories.
In September 2021, Janssen - a pharmaceutical subsidiary of Johnson & Johnson - announced that it has introduced its nine-month startup accelerator - a program for the digital health startup space to gain innovative ideas on predictive diagnostics to discover precision treatment and therapies.
With this step, the company aims to introduce digital tools to facilitate clinical trials in different disease areas, ultimately to discover treatments at much lower costs.
Through this program, the company will provide selected startups from the Europe, Middle East and Africa (EMEA) region with nine months of support as well as mentorship with members iPEPS - a French brain health incubator - and Janssen.
In October 2021, bioMérieux - a French multinational biotechnology company and a world leader in the area of in-vitro diagnostics - announced that it has launched predictive Diagnostics, which is the company’s new offering in the field of food safety and food quality.
The company’s Predictive Diagnostics offering combines traditional solutions vis-a-vis core microbiology with advanced technologies such as predictive modeling, data sequencing, and data science, declared the global R&D director – Food at bioMérieux.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
The Analyst’s Viewpoint
“Advancements in data-based technologies, data science, and data analytics formulates the base for the flourishing market for predictive diagnostics.
Manufacturers must, rather than simply recording crucial data, offer new insights, value, and action points for the treatment or therapies for avoiding impending health disorders", opines a lead analyst at Fact.MR
Rising prevalence of lifestyle diseases has bolstered the public awareness to make people health conscious. This is further triggering the adoption of predictive diagnostics. Market players will have to introduce convenient and simpler diagnostic tools that can help doctors as well as patients to gain access to precision treatment quickly.
COVID-19 Impact on the Predictive Diagnostics Market
While the demand for predictive diagnostics is expected to increase significantly across the world, the global outbreak of the novel coronavirus as well as increasing cases of new mutated Covid-19 strain has impacted the growth prospects of the predictive diagnostics market.
Manufacturers are facing operational issues as the world is likely to go back in the lockdown due to the incessant rise in the number of COVID-affected countries.
Most projects in Asia Pacific countries as well as European countries have been delayed due to constraints in supply chain operations and lack of site access. Manufacturers are expected to derive new investment strategies to tackle these issues and create a new growth trajectory to win during the COVID-19 pandemic.
Furthermore, the negative impacts of the COVID-19 pandemic will also coarse manufacturers to remodel their regional strategies by expanding their distributors’ networks across least-affected countries.
About the Report
Fact.MR has published a detailed and well-researched study on the growth projections of the predictive diagnostics market during the forecast period of 2021-2031.
The report includes analytics based on thorough studies about various factors that may boost or hinder the growth of the market in the coming years.
The report also highlights potential for growth and opportunities for all the stakeholders in the predictive diagnostics market during 2021 and 2031.
The team of seasoned analysts at Fact.MR has analyzed a wide range of growth parameters and derived actionable insights for market players to register astonishing growth in the predictive diagnostics market.
The unique recommendations and conclusions in the Fact.MR report can help stakeholders to plan their upcoming strategies to fetch remarkable profits in the predictive diagnostics market in the coming years.
The report also includes detailed regional insights about how the predictive diagnostics market will grow in various geographical areas and which factors will influence the growth prospects for local players.
This can further give market players a clear idea about the competitive landscape in the global as well as regional predictive diagnostics market.
Predictive Diagnostics Market: Segmentation
The study offers a detailed estimation and outlook of the predictive diagnostics market based on the test, indication, end user, and region.
-
By Test :
- PCR based
- NGS (sequencing) based
-
By Indication :
- Cancer
- Metabolic Disorders
- Neurological Disorders
- Musculoskeletal Diseases
- Others
-
By End User :
- Diagnostics
- Genetic Laboratories And Clinics
- Research And Academic Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global GDP Growth Outlook 4.1.2. Global Healthcare Outlook 4.1.3. Per Capita Healthcare Expenditure Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Emergence of Innovative technologies 4.2.2. Rapid Improvements in Microbiome Modulator market 4.2.3. Increasing adoption of Modern Healthcare Technologies 4.2.4. R&D Investment 4.2.5. Product Cost 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. Market Context 5.1. Key Regulations 5.2. Adoption of Predictive Diagnostics, By Region 5.3. Technological Development 5.4. Disease epidemiology 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product 6.4.2. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected recovery Quarter 6.8. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Global Predictive Diagnostics Market Value Analysis 2016 – 2020 and Forecast, 2021 – 2031 7.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020 7.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Test Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2016 – 2020 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2021 – 2031 8.3.1. PCR based 8.3.2. NGS (sequencing) based 8.4. Market Attractiveness Analysis By Test Type 9. Global Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Indication 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016 – 2020 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2021 – 2031 9.3.1. Cancer 9.3.2. Metabolic disorders 9.3.3. Neurological disorders 9.3.4. Musculoskeletal diseases 9.3.5. Others 9.4. Market Attractiveness Analysis By Indication 10. Global Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2016 – 2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 – 2031 10.3.1. Diagnostics 10.3.2. Genetic Laboratories And Clinics 10.3.3. Research And Academic Institutes 10.4. Market Attractiveness Analysis By End User 11. Global Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 – 2020 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Test Type 12.3.3. By Indication 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Latin America Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Test Type 13.3.3. By Indication 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Europe Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. Rest of Europe 14.3.2. By Test Type 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. South Asia Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Test Type 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. East Asia Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.1.4. Rest of East Asia 16.3.2. By Test Type 16.3.3. By Indication 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Oceania Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Test Type 17.3.3. By Indication 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. South Africa 18.3.1.3. Rest of Middle East and Africa 18.3.2. By Test Type 18.3.3. By Indication 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.5. Drivers and Restraints - Impact Analysis 19. Key and Emerging Countries Predictive Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. U.S. Predictive Diagnostics Market Analysis 19.2.1. By Test Type 19.2.2. By Indication 19.2.3. By End User 19.3. Canada Predictive Diagnostics Market Analysis 19.3.1. By Test Type 19.3.2. By Indication 19.3.3. By End User 19.4. Mexico Predictive Diagnostics Market Analysis 19.4.1. By Test Type 19.4.2. By Indication 19.4.3. By End User 19.5. Brazil Predictive Diagnostics Market Analysis 19.5.1. By Test Type 19.5.2. By Indication 19.5.3. By End User 19.6. U.K. Predictive Diagnostics Market Analysis 19.6.1. By Test Type 19.6.2. By Indication 19.6.3. By End User 19.7. Germany Predictive Diagnostics Market Analysis 19.7.1. By Test Type 19.7.2. By Indication 19.7.3. By End User 19.8. France Predictive Diagnostics Market Analysis 19.8.1. By Test Type 19.8.2. By Indication 19.8.3. By End User 19.9. Italy Predictive Diagnostics Market Analysis 19.9.1. By Test Type 19.9.2. By Indication 19.9.3. By End User 19.10. Spain Predictive Diagnostics Market Analysis 19.10.1. By Test Type 19.10.2. By Indication 19.10.3. By End User 19.11. BENELUX Predictive Diagnostics Market Analysis 19.11.1. By Test Type 19.11.2. By Indication 19.11.3. By End User 19.12. Russia Predictive Diagnostics Market Analysis 19.12.1. By Test Type 19.12.2. By Indication 19.12.3. By End User 19.13. China Predictive Diagnostics Market Analysis 19.13.1. By Test Type 19.13.2. By Indication 19.13.3. By End User 19.14. Japan Predictive Diagnostics Market Analysis 19.14.1. By Test Type 19.14.2. By Indication 19.14.3. By End User 19.15. South Korea Predictive Diagnostics Market Analysis 19.15.1. By Test Type 19.15.2. By Indication 19.15.3. By End User 19.16. India Predictive Diagnostics Market Analysis 19.16.1. By Test Type 19.16.2. By Indication 19.16.3. By End User 19.17. ASEAN Predictive Diagnostics Market Analysis 19.17.1. By Test Type 19.17.2. By Indication 19.17.3. By End User 19.18. Australia Predictive Diagnostics Market Analysis 19.18.1. By Test Type 19.18.2. By Indication 19.18.3. By End User 19.19. New Zealand Predictive Diagnostics Market Analysis 19.19.1. By Test Type 19.19.2. By Indication 19.19.3. By End User 19.20. GCC Countries Predictive Diagnostics Market Analysis 19.20.1. By Test Type 19.20.2. By Indication 19.20.3. By End User 19.21. Turkey Predictive Diagnostics Market Analysis 19.21.1. By Test Type 19.21.2. By Indication 19.21.3. By End User 19.22. South Africa Predictive Diagnostics Market Analysis 19.22.1. By Test Type 19.22.2. By Indication 19.22.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional footprint of Players 20.4.2. Product foot print by Players 20.4.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. Qiagen 21.3.1.1. Overview 21.3.1.2. Product Portfolio 21.3.1.3. Analyst Commentary 21.3.1.4. Key Financials 21.3.1.5. Recent Developments 21.3.1.6. Sales Footprint 21.3.1.7. Strategy Overview 21.3.1.7.1. Marketing Strategy 21.3.1.7.2. Product Strategy 21.3.1.7.3. Channel Strategy 21.3.2. Therawis 21.3.2.1. Overview 21.3.2.2. Product Portfolio 21.3.2.3. Analyst Commentary 21.3.2.4. Key Financials 21.3.2.5. Recent Developments 21.3.2.6. Sales Footprint 21.3.2.7. Strategy Overview 21.3.2.7.1. Marketing Strategy 21.3.2.7.2. Product Strategy 21.3.2.7.3. Channel Strategy 21.3.3. Myriad Genetics, Inc. 21.3.3.1. Overview 21.3.3.2. Product Portfolio 21.3.3.3. Analyst Commentary 21.3.3.4. Key Financials 21.3.3.5. Recent Developments 21.3.3.6. Sales Footprint 21.3.3.7. Strategy Overview 21.3.3.7.1. Marketing Strategy 21.3.3.7.2. Product Strategy 21.3.3.7.3. Channel Strategy 21.3.4. BIOMÉRIEUX SA 21.3.4.1. Overview 21.3.4.2. Product Portfolio 21.3.4.3. Analyst Commentary 21.3.4.4. Key Financials 21.3.4.5. Recent Developments 21.3.4.6. Sales Footprint 21.3.4.7. Strategy Overview 21.3.4.7.1. Marketing Strategy 21.3.4.7.2. Product Strategy 21.3.4.7.3. Channel Strategy 21.3.5. Hoffmann-La Roche 21.3.5.1. Overview 21.3.5.2. Product Portfolio 21.3.5.3. Analyst Commentary 21.3.5.4. Key Financials 21.3.5.5. Recent Developments 21.3.5.6. Sales Footprint 21.3.5.7. Strategy Overview 21.3.5.7.1. Marketing Strategy 21.3.5.7.2. Product Strategy 21.3.5.7.3. Channel Strategy 21.3.6. Thermo Fisher Scientific 21.3.6.1. Overview 21.3.6.2. Product Portfolio 21.3.6.3. Analyst Commentary 21.3.6.4. Key Financials 21.3.6.5. Recent Developments 21.3.6.6. Sales Footprint 21.3.6.7. Strategy Overview 21.3.6.7.1. Marketing Strategy 21.3.6.7.2. Product Strategy 21.3.6.7.3. Channel Strategy 21.3.7. Bio-Rad 21.3.7.1. Overview 21.3.7.2. Product Portfolio 21.3.7.3. Analyst Commentary 21.3.7.4. Key Financials 21.3.7.5. Recent Developments 21.3.7.6. Sales Footprint 21.3.7.7. Strategy Overview 21.3.7.7.1. Marketing Strategy 21.3.7.7.2. Product Strategy 21.3.7.7.3. Channel Strategy 21.3.8. Centogene N.V. 21.3.8.1. Overview 21.3.8.2. Product Portfolio 21.3.8.3. Analyst Commentary 21.3.8.4. Key Financials 21.3.8.5. Recent Developments 21.3.8.6. Sales Footprint 21.3.8.7. Strategy Overview 21.3.8.7.1. Marketing Strategy 21.3.8.7.2. Product Strategy 21.3.8.7.3. Channel Strategy 21.3.9. Predictive Oncology 21.3.9.1. Overview 21.3.9.2. Product Portfolio 21.3.9.3. Analyst Commentary 21.3.9.4. Key Financials 21.3.9.5. Recent Developments 21.3.9.6. Sales Footprint 21.3.9.7. Strategy Overview 21.3.9.7.1. Marketing Strategy 21.3.9.7.2. Product Strategy 21.3.9.7.3. Channel Strategy 21.3.10. Mylab Discovery Solutions Pvt. Ltd. 21.3.10.1. Overview 21.3.10.2. Product Portfolio 21.3.10.3. Analyst Commentary 21.3.10.4. Key Financials 21.3.10.5. Recent Developments 21.3.10.6. Sales Footprint 21.3.10.7. Strategy Overview 21.3.10.7.1. Marketing Strategy 21.3.10.7.2. Product Strategy 21.3.10.7.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 02: Global Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 03: Global Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 04: Global Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 05: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 06: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 07: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 08: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 09: Latin America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 10: Latin America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 11: Latin America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 12: Latin America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 13: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 15: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 16: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 17: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 18: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 19: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 20: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 21: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 22: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 23: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 24: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 25: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 26: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 27: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 28: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 29: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 30: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Table 31: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 32: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016–2020
Figure 02: Global Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021–2031
Figure 03: Global Predictive Diagnostics Market Absolute $ Opportunity Analysis, 2021–2031
Figure 04: Global Predictive Diagnostics Market Analysis by Test Type–2021 & 2031
Figure 05: Global Predictive Diagnostics Market Y-o-Y Growth Projections by Test Type, 2021 – 2031
Figure 06: Global Predictive Diagnostics Market Attractiveness Analysis By Test Type, 2021-2031
Figure 07: Global Predictive Diagnostics Market Analysis by Indication–2021 & 2031
Figure 08: Global Predictive Diagnostics Market Y-o-Y Growth Projections by Indication, 2021 – 2031
Figure 09: Global Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Figure 10: Global Predictive Diagnostics Market Analysis by End User –2021 & 2031
Figure 11: Global Predictive Diagnostics Market Y-o-Y Growth Projections by End User , 2021 – 2031
Figure 12: Global Predictive Diagnostics Market Attractiveness Analysis 2021-2031, By End User
Figure 13: Global Predictive Diagnostics Market Share Analysis (%) By Region, 2021 & 2031
Figure 14: Global Predictive Diagnostics Market Y-o-Y Growth (%) By Region, 2021–2031
Figure 15: Global Predictive Diagnostics Market Attractiveness Analysis 2021-2031, By Region
Figure 16: North America Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 17: North America Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 18: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 19: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 20: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 21: North America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 22: Latin America Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 23: Latin America Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 24: Latin America Medical America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 25: Latin America Medical America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 26: Latin America Medical America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 27: Latin America Medical America Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 28: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 29: Europe Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 30: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 31: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 32: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 33: Europe Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 34: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 35: East Asia Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 36: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 37: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 38: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 39: East Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 40: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 41: South Asia Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 42: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 43: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 44: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 45: South Asia Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 46: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 47: Oceania Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 48: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 49: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 50: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 51: Oceania Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 52: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis, 2016-2020
Figure 53: MEA Predictive Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 54: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Figure 55: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Test Type
Figure 56: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, Indication
Figure 57: MEA Predictive Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Figure 58: China Market Value Proportion Analysis, 2021
Figure 59: China Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 60: China. Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 61: China. Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 62: Global Vs. China Growth Comparison
Figure 63: India Market Value Proportion Analysis, 2021
Figure 64: India. Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 65: India. Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 66: India. Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 67: Global Vs. India Growth Comparison
Figure 68: Brazil Market Value Proportion Analysis, 2021
Figure 69: Brazil. Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 70: Brazil. Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 71: Brazil. Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 72: Global Vs. Brazil Growth Comparison
Figure 73: U.S Market Value Proportion Analysis, 2021
Figure 74: U.S. Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 75: U.S. Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 76: U.S. Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 77: Global Vs. U.S Growth Comparison
Figure 78: Canada Market Value Proportion Analysis, 2021
Figure 79: Canada Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 80: Canada Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 81: Canada Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 82: Global Vs. Canada Growth Comparison
Figure 83: Mexico Market Value Proportion Analysis, 2021
Figure 84: Mexico Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 85: Mexico Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 86: Mexico Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 87: Global Vs. Mexico Growth Comparison
Figure 88: Argentina Market Value Proportion Analysis, 2021
Figure 89: Argentina Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 90: Argentina Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 91: Argentina Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 92: Global Vs. Argentina Growth Comparison
Figure 93: U.K. Market Value Proportion Analysis, 2021
Figure 94: U.K. Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 95: U.K. Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 96: U.K. Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 97: Global Vs. U.K Growth Comparison
Figure 98: Germany Market Value Proportion Analysis, 2021
Figure 99: Germany Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 100: Germany Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 101: Germany Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 102: Global Vs. Germany Growth Comparison
Figure 103: France Market Value Proportion Analysis, 2021
Figure 104: France Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 105: France Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 106: France Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 107: Global Vs. France Growth Comparison
Figure 108: Italy Market Value Proportion Analysis, 2021
Figure 109: Italy Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 110: Italy Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 111: Italy Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 112: Global Vs. Italy Growth Comparison
Figure 113: Spain Market Value Proportion Analysis, 2021
Figure 114: Spain Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 115: Spain Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 116: Spain Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 117: Global Vs. Spain Growth Comparison
Figure 118: Russia Market Value Proportion Analysis, 2021
Figure 119: Russia Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 120: Russia Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 121: Russia Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 122: Global Vs. Russia Growth Comparison
Figure 123: Japan Market Value Proportion Analysis, 2021
Figure 124: Japan Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 125: Japan Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 126: Japan Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 127: Global Vs. Japan Growth Comparison
Figure 128: South Korea Market Value Proportion Analysis, 2021
Figure 129: South Korea Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 130: South Korea Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 131: South Korea Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 132: Global Vs. South Korea Growth Comparison
Figure 133: Indonesia Market Value Proportion Analysis, 2021
Figure 134: Indonesia Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 135: Indonesia Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 136: Indonesia Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 137: Global Vs. Indonesia Growth Comparison
Figure 138: Malaysia Market Value Proportion Analysis, 2021
Figure 139: Malaysia Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 140: Malaysia Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 141: Malaysia Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 142: Global Vs. Malaysia Growth Comparison
Figure 143: Thailand Market Value Proportion Analysis, 2021
Figure 144: Thailand Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 145: Thailand Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 146: Thailand Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 147: Global Vs. Thailand Growth Comparison
Figure 148: Australia Market Value Proportion Analysis, 2021
Figure 149: Australia Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 150: Australia Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 151: Australia Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 152: Global Vs. Australia Growth Comparison
Figure 153: New Zealand Market Value Proportion Analysis, 2021
Figure 154: New Zealand Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 155: New Zealand Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 156: New Zealand Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 157: Global Vs. New Zealand Growth Comparison
Figure 158: South Africa Market Value Proportion Analysis, 2021
Figure 159: South Africa Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 160: South Africa Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 161: South Africa Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 162: Global Vs. South Africa Growth Comparison
Figure 163: GCC Countries Market Value Proportion Analysis, 2021
Figure 164: GCC Countries Predictive Diagnostics Market Share Analysis (%) By Test Type, 2021 & 2031
Figure 165: GCC Countries Predictive Diagnostics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 166: GCC Countries Predictive Diagnostics Market Share Analysis (%) By End User, 2021 & 2031
Figure 167: Global Vs. GCC Countries Growth Comparison
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which region will act as major contributor of Predictive Diagnostics Market?
The adoption of predictive diagnostic equipment is significantly high in US and Europe.
Predictive Diagnostics Market